<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>1(1)</volume><submitter>Chu H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person and, in 2 months, has caused more than 82 000 laboratory-confirmed cases of coronavirus disease 2019 (COVID-19) and 2800 deaths in 46 countries. The total number of cases and deaths has surpassed that of the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV). Although both COVID-19 and severe acute respiratory syndrome (SARS) manifest as pneumonia, COVID-19 is associated with apparently more efficient transmission, fewer cases of diarrhoea, increased mental confusion, and a lower crude fatality rate. However, the underlying virus-host interactive characteristics conferring these observations on trans</pubmed_abstract><journal>The Lancet. Microbe</journal><pagination>e14-e23</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7173822</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.</pubmed_title><pmcid>PMC7173822</pmcid><pubmed_authors>Cai JP</pubmed_authors><pubmed_authors>Tsoi HW</pubmed_authors><pubmed_authors>Lung DC</pubmed_authors><pubmed_authors>Chu AW</pubmed_authors><pubmed_authors>Chan WM</pubmed_authors><pubmed_authors>Chan KH</pubmed_authors><pubmed_authors>Shuai H</pubmed_authors><pubmed_authors>Chik KK</pubmed_authors><pubmed_authors>Ip JD</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors><pubmed_authors>To KK</pubmed_authors><pubmed_authors>Tsang OT</pubmed_authors><pubmed_authors>Chu H</pubmed_authors><pubmed_authors>Yip CC</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Chai Y</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Chan JF</pubmed_authors><pubmed_authors>Yuen TT</pubmed_authors><pubmed_authors>Fung AY</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Hu B</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Tsang JO</pubmed_authors><pubmed_authors>Yuen KY</pubmed_authors><pubmed_authors>Kok KH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.</name><description>&lt;h4>Background&lt;/h4>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person and, in 2 months, has caused more than 82 000 laboratory-confirmed cases of coronavirus disease 2019 (COVID-19) and 2800 deaths in 46 countries. The total number of cases and deaths has surpassed that of the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV). Although both COVID-19 and severe acute respiratory syndrome (SARS) manifest as pneumonia, COVID-19 is associated with apparently more efficient transmission, fewer cases of diarrhoea, increased mental confusion, and a lower crude fatality rate. However, the underlying virus-host interactive characteristics conferring these observations on trans</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2026-05-01T22:25:25.885Z</modification><creation>2025-05-29T21:15:18.237Z</creation></dates><accession>S-EPMC7173822</accession><cross_references><pubmed>32835326</pubmed><doi>10.1016/S2666-5247(20)30004-5</doi></cross_references></HashMap>